Thursday, November 12

11:00 a.m. to 1:00 p.m.

Somerville Elks, Bridgewater

According to the 2024 National Health Interview Survey, 26.5% of adults diagnosed with diabetes or other medical conditions used GLP-1 injectables.

In this symposium, understand GLP-1 agonists, the different types of medication, how they work, the benefits of use, who qualifies to take them, any side effects, the correlation between weight loss and chronic disease risk reduction, the different medical conditions for which GLP-1s are prescribed, risk factors of these conditions, causes, symptoms, diagnostic tests and alternate treatments as well as prevention strategies.

A light healthy lunch will be served.

Karan Grover, MD, PharmD, general and bariatric surgeon, director of medical weight loss, advanced surgical and bariatrics